Published in J Neurol Neurosurg Psychiatry on May 01, 2001
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Huntington's disease. Pathogenesis and management. N Engl J Med (1986) 2.77
Oxidative stress in Huntington's disease. Brain Pathol (1999) 1.80
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. J Cereb Blood Flow Metab (1995) 1.54
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51
Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain (1990) 1.44
Positron emission tomography in the early diagnosis of Huntington's disease. Neurology (1986) 1.33
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain (1997) 1.24
The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Mol Cell Biochem (1981) 1.09
Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J Cereb Blood Flow Metab (1992) 1.09
Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy. Neurology (1978) 1.03
A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. J Comput Assist Tomogr (1980) 1.03
Cortical glucose metabolism in Huntington's disease. Neurology (1992) 1.03
Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol Biol (Paris) (1996) 0.96
Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry (1992) 0.93
The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry. J Comp Neurol (1979) 0.92
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. Eur Arch Psychiatry Clin Neurosci (1994) 0.90
Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry (1988) 0.89
Computed tomography for Huntington's disease. Neuroradiology (1977) 0.89
Benzodiazepine and GABA receptors in early Huntington's disease. Neurology (1984) 0.89
Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Ann Neurol (1993) 0.82
Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil. Eur J Pharmacol (1993) 0.80
The small world of metabolism. Nat Biotechnol (2000) 6.35
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med (1986) 4.18
The PILATUS 1M detector. J Synchrotron Radiat (2006) 4.16
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet (1998) 3.28
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet (2000) 2.84
Innovation and robustness in complex regulatory gene networks. Proc Natl Acad Sci U S A (2007) 2.70
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol (2010) 2.32
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med (1999) 2.06
The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol (2009) 2.04
Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol (1999) 1.99
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
A mechanism for increased contractile strength of human pennate muscle in response to strength training: changes in muscle architecture. J Physiol (2001) 1.89
How can acute mountain sickness be quantified at moderate altitude? J R Soc Med (1996) 1.84
Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab (1995) 1.82
Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science (1987) 1.81
Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol (1981) 1.75
Robustness and evolution: concepts, insights and challenges from a developmental model system. Heredity (Edinb) (2006) 1.75
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage (2000) 1.64
Generalizable patterns in neuroimaging: how many principal components? Neuroimage (1999) 1.61
Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology (2001) 1.60
Basic research and 12 years of clinical experience in computer-assisted navigation technology: a review. Int J Oral Maxillofac Surg (2005) 1.59
Negative regulation of transcription of the Saccharomyces cerevisiae catalase T (CTT1) gene by cAMP is mediated by a positive control element. EMBO J (1991) 1.59
Computer-aided navigation in secondary reconstruction of post-traumatic deformities of the zygoma. J Craniomaxillofac Surg (1997) 1.58
Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Exp Neurol (2007) 1.58
Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke (2001) 1.57
Heat shock factor-independent heat control of transcription of the CTT1 gene encoding the cytosolic catalase T of Saccharomyces cerevisiae. J Biol Chem (1991) 1.55
Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke (1994) 1.52
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer (2004) 1.52
Prevalence of stroke and stroke symptoms: a population-based survey of 28,090 participants. Neuroepidemiology (2008) 1.50
Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J Neurol Neurosurg Psychiatry (1998) 1.49
Hypoglycemia and pulmonary edema: a forgotten association. Diabetes Care (2000) 1.47
Regional blood flow in internal carotid distribution during migraine attack. Br Med J (1969) 1.47
A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A (1998) 1.47
[Hypo- and hypernatremia]. Dtsch Med Wochenschr (2010) 1.46
Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J (2002) 1.46
alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol (1995) 1.46
S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl (2001) 1.43
Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry (1995) 1.41
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium. Pharmacopsychiatry (2009) 1.40
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet (2005) 1.38
Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol (1983) 1.36
Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'. J Public Health (Oxf) (2006) 1.35
Cerebral autoregulation. Stroke (1984) 1.33
Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry (2005) 1.32
Regional cerebral blood flow: a comparison of 8-detector and 16-detector instrumentation. J Nucl Med (1969) 1.31
Solitary fibrous tumor in the thigh: review of the literature. J Cancer Res Clin Oncol (2005) 1.30
Successful overweight prevention in adolescents by increasing physical activity: a 4-year randomized controlled intervention. Int J Obes (Lond) (2008) 1.29
The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP. Clin Genet (2007) 1.27
Long-term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord (1997) 1.26
The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology (1998) 1.26
Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest (1984) 1.24
Neurologic complications of cerebral angiography. A retrospective study of complication rate and patient risk factors. Acta Radiol (2000) 1.23
Cerebral activation during micturition in normal men. Brain (2000) 1.22
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res (1980) 1.22
The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron. Am J Med Genet A (2009) 1.21
Capillary circulation in the brain. Cerebrovasc Brain Metab Rev (1992) 1.20
Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol (1991) 1.20
Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol (1999) 1.19
Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A (1994) 1.19
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
Cerebral vasomotor paralysis during migraine attack. Arch Neurol (1973) 1.18
Fixation of zygomatic fractures with a new biodegradable copolymer osteosynthesis system. Preliminary results. Int J Oral Maxillofac Surg (1998) 1.17
Phaeochromocytomas and sympathetic paragangliomas. Br J Surg (2009) 1.17
Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults. J Infect Dis (2000) 1.17
Delayed onset of fatal basilar thrombotic embolus after whiplash injury. Stroke (1995) 1.17
The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab (1988) 1.15
Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum Mol Genet (1993) 1.15
Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke (2001) 1.15
Cardiopulmonary resuscitation in the aged. A prospective survey. N Engl J Med (1984) 1.14
Cerebral hyperemia in electrically induced epileptic seizures. Arch Neurol (1973) 1.14
The intact retroviral Env glycoprotein of human foamy virus is a trimer. J Virol (2000) 1.13
Site-directed mutagenesis of Thermus thermophilus elongation factor Tu. Replacement of His85, Asp81 and Arg300. Eur J Biochem (1995) 1.13
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol (2001) 1.13
Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology (2000) 1.13
Adaptation of Saccharomyces cerevisiae to saline stress through laboratory evolution. J Evol Biol (2011) 1.12
Anti-inflammatory effects of 13-Cis-retinoic acid. An in vivo study. Arch Dermatol Res (1981) 1.12
Identification of a co-repressor binding site in catabolite control protein CcpA. Mol Microbiol (1998) 1.12
Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol (1996) 1.11
Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36. Pain Med (2000) 1.11
Regional cerebral blood flow and its autoregulation in patients with transient focal cerebral ischemic attacks. Neurology (1970) 1.10
No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes (1999) 1.10
Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite (2005) 1.10
Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting. J Neurosurg (1987) 1.10
Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol (2004) 1.09
Acute mountain sickness at moderate altitudes. Ann Intern Med (1993) 1.09
Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet (2001) 1.09
Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia (2006) 1.08
Herpes simplex keratitis in renal transplant patients. Br J Ophthalmol (1991) 1.07
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Eur J Cancer (2001) 1.07